Net Profit Margin ratio Analysis of Marksans Pharma - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPoint
Beta&Vols
Tech ChartsLatest FY NPM
Period Ending - Mar-25
Indecisive NPM
14.41
Period Ending - Mar-24
Indecisive NPM
14.41
Growth
0 %
Trailing Twelve Months NPM
Period Ending - Mar-25
Indecisive NPM
12.85
Most recent Quarter NPM
Period Ending - Dec-25
Good NPM
15.00
NPM Analysis of Marksans Pharma
| NPM Ratio of MARKSANS has fallen by 0 % Compared to previous Financial Year. |
| NPM Ratio with value of 17.33 was highest in Year Mar-21 in last Five Years. |
| NPM Ratio with value of 12.53 was lowest in Year Mar-22 in last Five Years. |
| Latest NPM Ratio with value of 14.41 is lower than Average NPM of 14.61 in last five years. |
Other NPM Related Info of MARKSANS that may interest you.
Marksans Pharma Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| MARKSANS | 180.18 | 178.92 | 0.704 % | Health Services |
Defination of Net Profit Margin
Net Margin is the company's Net Profit divided by the Total Revenue. This profitability metric indicates how much a net profit is generated for each rupee of revenue earned. In simple terms, it tells how much the company is generating profit for each rupee of revenue earned in percentage. It measures the company's profitability and management's capability to manage its expenses to generate profit. more ..
NPM Related Ratios
| ReturnOnEquity | EBITDAMargin |
Tsr Profitability Index
| No Significant Profitability | Screener |
FY - Historical Net Profit Margin of Marksans Pharma
| Period | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 |
|---|---|---|---|---|---|---|---|
| NPM | 14.41 | 14.41 | 14.38 | 12.53 | 17.33 | 10.32 | 7.65 |
| Change | 0 % | 0.198 % | 14.75 % | -27.71 % | 68.00 % | 34.95 % | 111.84 % |
| Price | 222.47 | 151.90 | 70.40 | 45.50 | 49.95 | 13.90 | 24.95 |
| Price Change | 46.46 % | 115.77 % | 54.73 % | -8.91 % | 259.35 % | -44.29 % | -21.17 % |